Editorial
Published on 06 Nov 2023
Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1306117
- 2,568 views
Type at least 3 characters
543 articles
Articles
Original Research
Published on 03 Nov 2023
The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1271165
- 1,728 views
Original Research
Published on 02 Nov 2023
Home-administered transcranial direct current stimulation with asynchronous remote supervision in the treatment of depression: feasibility, tolerability, and clinical effectiveness
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1206805
- 4,027 views
- 1 citation
Case Report
Published on 25 Oct 2023
Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1197697
- 2,750 views
Editorial
Published on 19 Oct 2023
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1305478
- 2,605 views
Case Report
Published on 10 Oct 2023
Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1257984
- 3,692 views
- 3 citations
Original Research
Published on 06 Oct 2023
Paliperidone long-acting injection in the treatment of an adolescent with schizophrenia with fluctuating mental symptoms during menstrual period: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1276983
- 2,785 views
- 1 citation
Original Research
Published on 03 Oct 2023
Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1257755
- 2,665 views
- 3 citations
Systematic Review
Published on 22 Sep 2023
Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1248397
- 12,642 views
- 2 citations
Perspective
Published on 20 Sep 2023
Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1159843
- 3,336 views
- 1 citation
Methods
Published on 19 Sep 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1268832
- 13,396 views
- 6 citations
Original Research
Published on 19 Sep 2023
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1199642
- 44,896 views
- 30 citations
Original Research
Published on 15 Sep 2023
Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1256264
- 1,916 views
Original Research
Published on 30 Aug 2023
Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1160442
- 3,337 views
Editorial
Published on 21 Aug 2023
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1266566
- 1,225 views
Original Research
Published on 21 Aug 2023
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1210155
- 10,588 views
- 8 citations